ATRC Financial Facts
Research and development expenses: 3.51MGross profit: 14.09M
See Full Income Statement
Accumulated deficit: -112.69M
Short-term investments: 5.25M
See Full Balance Sheet
Earnings History for AtriCure, Inc. (ATRC)
|
Expand Research on ATRC
| Next EPS Date | 8/1/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -11.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/13  |
 |
Q113 | -$0.10 | -$0.11 | +$0.01 | $19.4M | $18.62M | N/A / N/A | = | +17.1% | Details |
| 2/28/13 |
|
Q412 | -$0.12 | -$0.10 | -$0.02 | $18.4M | $18.46M | N/A / N/A | = | +4.2% | Details |
| 11/1/12 |
|
Q312 | -$0.16 | -$0.12 | -$0.04 | $16.1M | $17.29M | N/A / N/A | N/A | +56.5% | Details |
| 8/2/12 |
Q212 | -$0.08 | -$0.08 | $0.00 | $18.3M | $18M | N/A / N/A | N/A | +14.2% | Details | |
| 11/30/99 | |
Q112 | $0.00 | -$0.14 | +$0.14 | N/A | $16.38M | N/A / N/A | N/A | +13.8% | Details |
| 2/27/12 |
|
Q411 | -$0.13 | -$0.08 | -$0.05 | $16.8M | $17.16M | N/A / N/A | N/A | -9.3% | Details |
| 11/1/11 |
|
Q311 | -$0.07 | -$0.08 | +$0.01 | $15.2M | $15.88M | N/A / N/A | N/A | -17.1% | Details |
| 8/2/11 |
|
Q211 | -$0.06 | -$0.05 | -$0.01 | $16.8M | $16.21M | N/A / N/A | N/A | -21.7% | Details |
